Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients

Journal of Psychiatry and Neuroscience

Volumn 35, Issue 1, 2010, Pages 59-62

  Wood, Paul L ^a   Mankidy, Rishikesh ^b   Ritchie, Shawn ^b   Heath, Doug ^b   Wood, Julie A ^b   Flax, John ^c   Goodenowe, Dayan B ^b  

^a Phreedom Pharma   (Canada)

^b Phenomenome Discoveries   (Canada)

^c PrecisionMed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; PLASMALOGEN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TANDEM MASS SPECTROMETRY;

EID: 75449092205     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: 10.1503/jpn.090059     Document Type: Article

References (31)

1. Han X, Holtzman DM, McKeel DW Jr. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem 2001;77:1168-80.
2. Ginsberg L, Rafique S, Xuereb JH, et al. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res 1995;698:223-6.
3. Gorgas K, Teigler A, Komljenovic D, Just WW. The ether lipiddeficient mouse: tracking down plasmalogen functions. Biochim Biophys Acta 2006;1763:1511-26.
4. Brites P, Mooyer PA, El Mrabet L, et al. Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 2009;132:482-92.
5. Kavcic V, Ni H, Zhu T, et al. White matter integrity linked to functional impairments in aging and early Alzheimer's disease. Alzheimers Dement 2008;4:381-9.
6. Wood JA, Wood PL, Ryan R, et al. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha-2-macroglobulin and C-reactive protein. Brain Res 1993;629:245-52.
7. Scott BL, Bazan NG. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci U S A 1989;86:2903-7.
8. Hashimoto M, Hossain S, Masumura S. Effect of aging on plasma membrane fluidity of rat aortic endothelial cells. Exp Gerontol 1999;34:687-98.
9. Hashimoto M, Hossain S, Tanabe Y, et al. Effects of aging on the relation of adenyl purine release with plasma membrane fluidity of arterial endothelial cells. Prostaglandins Leukot Essent Fatty Acids 2005;73:475-83.
10. Xiu J, Nordberg A, Qi X, et al. Influence of cholesterol and lova - statin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes. Neurochem Int 2006;49:459-65.
11. Miersch S, Espey MG, Chaube R, et al. Plasma membrane cholesterol content affects nitric oxide diffusion dynamics and signaling. J Biol Chem 2008;283:18513-21.
12. Guo J, Chi S, Xu H, et al. Effects of cholesterol levels on the excitability of rat hippocampal neurons. Mol Membr Biol 2008;25:216-23.
13. Amatore C, Arbault S, Guille M, et al. The nature and efficiency of neurotransmitter exocytosis also depend on physicochemical parameters. ChemPhysChem 2007;8:1597-605.
14. Favrelière S, Perault MC, Huguet F, et al. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging 2003;24:233-43.
15. Nagan N, Hajra AK, Larkins LK, et al. Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol. Biochem J 1998;332:273-9.
16. Cutler RG, Kelly J, Storie K, et al. Involvement of oxidative stressinduced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 2004; 101:2070-5.
17. Goodenowe DB, Cook LL, Liu J, et al. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. J Lipid Res 2007;48:2485-98.
18. Mohs RC, Davis BM, Johns CA, et al. Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry 1985; 142:28-33.
19. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
20. Conquer JA, Tierney MC, Zecevic J, et al. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000;35:1305-12.
21. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-6.
22. Suh GH, Ju YS, Yeon BK, et al. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline. Int J Geriatr Psychiatry 2004;19:817-24.
23. Moon WJ, Kim HJ, Roh HG, et al. Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: Does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects? AJNR Am J Neuroradiol 2008;29:1308-13.
24. Danesh-Meyer HV, Birch H, Ku JY, et al. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 2006;67:1852-4.
25. Martínez M, Vázquez E, García-Silva MT, et al. Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am J Clin Nutr 2000;71(Suppl):376S- 85S.
26. Rovira A, Mínguez B, Aymerich FX, et al. Decreased white matter lesion volume and improved cognitive function after liver transplantation. Hepatology 2007;46:1485-90.
27. Périchon R, Bourre JM, Kelly JF, et al. The role of peroxisomes in aging. Cell Mol Life Sci 1998;54:641-52.
28. Das AK, Hajra AK. High incorporation of dietary 1-O-heptadecyl glycerol into tissue plasmalogens of young rats. FEBS Lett 1988; 227: 187-90.
29. Oswald EO, Anderson CE, Piantadosi C, et al. Metabolism of alkyl glyceryl ethers in the rat. Lipids 1968;3:51-8.
30. Bickerstaffe R, Mead JF. Metabolism of chimyl alcohol and phosphatidyl ethanolamine in the rat brain. Lipids 1968;3:317-20.
31. Das AK, Holmes RD, Wilson GN, et al. Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents. Lipids 1992;27:401-5.